Regulus Therapeutics | Attività Correnti



Current Assets Cambiamento Data
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Biogen USD 7.63B 169.2M 2025-03
Celldex Therapeutics USD 693.76M 53.4M 2025-03
Cipla INR 232.89B 23.43B 2025-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 106M 8.83M 2024-12
CSL USD 11.31B 540M 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Grifols EUR 5.73B 404.28M 2024-12
Incyte USD 3.23B 7.24M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Ligand Pharmaceuticals USD 309.32M 22.24M 2025-03
Merck USD 35.5B 3.28B 2025-03
Sanofi 42.59B 12.51B 2024-12
Takeda JPY 2.52T 233.1B 2025-03



Regulus Therapeutics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.